Millions of Americans with obesity are eagerly awaiting a powerful new drug from Eli Lilly called retatrutide, which has demonstrated bariatric-surgery levels of weight loss. Some aren’t even waiting for approval from the Food and Drug Administration, instead racing to acquire it through sketchy means.
But STAT has learned that Eli Lilly and the FDA have allowed one person to gain access to the drug through the FDA’s “compassionate use” program, a pathway that gives patients with serious and immediately life-threatening medical issues access to experimental treatments.
This person was a 79-year-old man at the time the request was made in April, according to three sources familiar with the matter. Those sources, who requested anonymity due to fear of reprisals, said it drew the interest of top health officials, suggesting the person receiving this drug was well connected.
An obese man who was 79 years old in April and who is politically connected enough to get top FDA officials interested in intervening to give him the drug.
I wonder who that could be......
I kinda doubt it's him. Not that he wouldn't jump the queue for anything he thought would benefit him. I doubt it because to my eye, he's put on at least 20 lbs in the past few months. If he is taking it, he's a pretty shitty advertisement for it.
ReplyDelete